Literature DB >> 12499176

Antimicrobial susceptibilities of Campylobacter strains isolated from Finnish subjects infected domestically or from those infected abroad.

Hilpi Rautelin1, Antti Vierikko, Marja-Liisa Hänninen, Martti Vaara.   

Abstract

The in vitro susceptibilities of 678 Campylobacter jejuni and Campylobacter coli strains isolated from stool samples of the same number of Finnish subjects were studied. A total of 523 patients, representing inhabitants from throughout Finland, had not traveled abroad within the 2 weeks prior to becoming ill, whereas 155 persons had presumably acquired their infections abroad. The antimicrobial agents studied were erythromycin, ciprofloxacin, levofloxacin, trovafloxacin, and moxifloxacin. The MICs of these antimicrobial agents were determined by the agar dilution method. The growth of all domestic isolates was inhibited by erythromycin at concentrations of 4 microg/ml, and for these isolates the fluoroquinolone MICs at which 90% of isolates are inhibited (MIC(90)s) ranged from 0.06 to 0.5 microg/ml. For the foreign isolates, the erythromycin MIC(90) was still low (4 microg/ml), but their susceptibilities to fluoroquinolones were clearly reduced (MIC(90)s, 8 to 64 microg/ml). Of the four different fluoroquinolones studied, ciprofloxacin was the least active (MIC(90), 64 micro g/ml).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12499176      PMCID: PMC148994          DOI: 10.1128/AAC.47.1.102-105.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Ciprofloxacin- and azithromycin-resistant Campylobacter causing traveler's diarrhea in U.S. troops deployed to Thailand in 1994.

Authors:  G S Murphy; P Echeverria; L R Jackson; M K Arness; C LeBron; C Pitarangsi
Journal:  Clin Infect Dis       Date:  1996-05       Impact factor: 9.079

2.  Infection with ciprofloxacin-resistant Campylobacter jejuni in travellers returning from Asia.

Authors:  M A Slavin; I Jennens; W Tee
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-04       Impact factor: 3.267

3.  Norfloxacin resistance in Campylobacter jejuni and Campylobacter coli isolates from Swedish patients.

Authors:  E Sjögren; G B Lindblom; B Kaijser
Journal:  J Antimicrob Chemother       Date:  1997-08       Impact factor: 5.790

4.  Antimicrobial susceptibilities of Campylobacter strains isolated from food animals in Belgium.

Authors:  M Van Looveren; G Daube; L De Zutter; J M Dumont; C Lammens; M Wijdooghe; P Vandamme; M Jouret; M Cornelis; H Goossens
Journal:  J Antimicrob Chemother       Date:  2001-08       Impact factor: 5.790

5.  Ciprofloxacin resistance in Campylobacter jejuni evolves rapidly in chickens treated with fluoroquinolones.

Authors:  Patrick F McDermott; Sonya M Bodeis; Linda L English; David G White; Robert D Walker; Shaohua Zhao; Shabbir Simjee; David D Wagner
Journal:  J Infect Dis       Date:  2002-02-08       Impact factor: 5.226

6.  Typing of human Campylobacter jejuni isolates in Finland by pulsed-field gel electrophoresis.

Authors:  M L Hänninen; S Pajarre; M L Klossner; H Rautelin
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

7.  Antimicrobial resistance of clinical strains of Campylobacter jejuni subsp. jejuni isolated from 1985 to 1997 in Quebec, Canada.

Authors:  C Gaudreau; H Gilbert
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

8.  Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent.

Authors:  R A Kuschner; A F Trofa; R J Thomas; C W Hoge; C Pitarangsi; S Amato; R P Olafson; P Echeverria; J C Sadoff; D N Taylor
Journal:  Clin Infect Dis       Date:  1995-09       Impact factor: 9.079

9.  Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland.

Authors:  H Rautelin; O V Renkonen; T U Kosunen
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

10.  Susceptibilities of fluoroquinolone-resistant strains of Campylobacter jejuni to 11 oral antimicrobial agents.

Authors:  J L Gomez-Garces; R Cogollos; J L Alos
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

View more
  4 in total

1.  Activities of telithromycin, erythromycin, fluoroquinolones, and doxycycline against Campylobacter strains isolated from Finnish subjects.

Authors:  Daniela Schönberg-Norio; Marja-Liisa Hänninen; Marja-Leena Katila; Suvi-Sirkku Kaukoranta; Markku Koskela; Erkki Eerola; Jaakko Uksila; Sini Pajarre; Hilpi Rautelin
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

2.  Campylobacter jejuni isolates in Finnish patients differ according to the origin of infection.

Authors:  Benjamin Feodoroff; Patrik Ellström; Heidi Hyytiäinen; Seppo Sarna; Marja-Liisa Hänninen; Hilpi Rautelin
Journal:  Gut Pathog       Date:  2010-12-20       Impact factor: 4.181

3.  Quinolone-resistant Campylobacter infections: risk factors and clinical consequences.

Authors:  Jørgen Engberg; Jakob Neimann; Eva Møller Nielsen; Frank Møller Aerestrup; Vivian Fussing
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883

4.  Antimicrobial Susceptibility Profiles of Human Campylobacter jejuni Isolates and Association with Phylogenetic Lineages.

Authors:  Wonhee Cha; Rebekah Mosci; Samantha L Wengert; Pallavi Singh; Duane W Newton; Hossein Salimnia; Paul Lephart; Walid Khalife; Linda S Mansfield; James T Rudrik; Shannon D Manning
Journal:  Front Microbiol       Date:  2016-04-26       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.